It is a broadly described annual report of Beacon Pharmaceuticals Limited in the year of 2012. During the financial year, The Company’s Sales Turnover has been increased by 33.25% over last year (i.e. 2011) and rose to Tk. 979.43 million. The Company’s total operating revenue was BDT 979,436,050.00 in 2012 as against BDT 734,972,610.00 of 2011. Operation profit has been increased from BDT 266.515,391.00 to BDT 339.787.826.00 representing an increase of 27.50 percent over last year. Net profit has been reduced from BDT 111.601,475.00 to 75,261.161.00 representing a decrease of 32.56 percent due to charging high financial expense and reducing income from other sources. Earnings per share were BDT 0.33 as against BDT 0.51 of 2011, which has been decreased by 35.29% over last year.
The Board of Directors of the Company has not recommended any dividend for the year ended 30th June 2012. These financial statements are presented in Bangladesh Taka (Taka/Tk/BDT) which is the company’s functional currency. All financial information presented in Taka has been rounded off to the nearest Taka.
More Annual Report of Beacon Pharmaceuticals Limited:
- Annual Report 2010 of Beacon Pharmaceuticals Limited
- Annual Report 2012 of Beacon Pharmaceuticals Limited
- Annual Report 2013 of Beacon Pharmaceuticals Limited
- Annual Report 2014 of Beacon Pharmaceuticals Limited
- Annual Report 2015 of Beacon Pharmaceuticals Limited
- Annual Report 2016 of Beacon Pharmaceuticals Limited
